Argon Medical Productions & Vertrieb Gesellschaft MBH & CO
3 extracted findings · 3 model-assigned issue types
FDA source excerpt, selected passage
Complaints involving potential device failures, such as the failure of dental implants to osseointegrate, were not investigated as required.
Findings and supporting evidence
Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.
Complaints involving potential device failures, such as osseointegration failure, were not investigated as required.
Supporting FDA text
Source excerpt · automated text-match checkComplaints involving potential device failures, such as the failure of dental implants to osseointegrate, were not investigated as required.
The MDR procedure lacks internal systems for timely identification, communication, and evaluation of reportable events.
Supporting FDA text
Source excerpt · automated text-match checkThe procedure does not establish internal systems that provide for timely and effective identification, communication, and evaluation of events that may be subject to MDR requirements, as required by 21 CFR 803.17(a)(1).
The MDR procedure lacks internal systems for timely transmission of complete medical device reports.
Supporting FDA text
Source excerpt · automated text-match checkThe procedure does not establish internal systems that provide for timely transmission of complete medical device reports, as required by 21 CFR 803.17(a)(3).
The firm failed to submit MDR reports within 30 days for serious injuries involving osseointegration failure.
Supporting FDA text
Source excerpt · automated text-match checkFailure to submit a report to FDA no later than 30 calendar days after the day that your firm received or otherwise became aware of information, from any source, that reasonably suggests that a device that your firm markets may have caused or contributed to a death or serious injury, as required by 21 CFR 803.50(a)(1).
Labels of K3Pro Kronus Dental implant devices do not bear a unique device identifier (UDI).
Supporting FDA text
Source excerpt · automated text-match checkThe labels of the K3Pro Kronus Dental implant devices do not bear such a UDI.
The K3Pro XP-Line device label lacks UDI in easily readable plain-text.
Supporting FDA text
Source excerpt · automated text-match checkthere is no UDI presented in easily readable plain-text on the label of the K3Pro Rapid (Ref 40009K3PRO.R), K3Pro XP-Line (Ref BSP.XP 35020/3), and K3Pro S-line (Ref 45011K3PRO.S) (see 21 CFR 801.40(a)(1))
The K3Pro XP-Line device label lacks UDI in machine-readable form using AIDC technology.
Supporting FDA text
Source excerpt · automated text-match checkthere is no UDI presented in machine-readable form that uses automatic identification and data capture (AIDC) technology on the label of K3Pro XP-Line (Ref BSP.XP 35020/3) (see 21 CFR 801.40(a)(2))
The firm failed to submit required information to GUDID for the K3Pro XP-Line devices.
Supporting FDA text
Source excerpt · automated text-match checkhas not submitted to GUDID information required by 21 CFR Part 830, subpart E, respecting these devices.
Findings extracted from the letter
Selected FDA passages, not the complete letter.
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
What FDA requested
Model-assisted summary. Consult the letter for complete requests and conditions.
- Provide documentation and evidence of corrective actions for complaint handling, including revised process instructions, work instructions, and forms.
- Provide English-translated documents for the revised MDR procedure (AA_002) and evidence of staff training.
- Provide documentation of the retrospective review of complaints from the past two years to assess reportability under MDR requirements.
- Provide documentation of corrections and/or corrective actions for UDI labeling and GUDID submission.
- Provide a translation of documentation not in English to facilitate review.
Sections and clauses cited
As cited in this historical letter, not a statement of current regulatory requirements.